Scarica l'app Stockscreener
0.3181
3.78%
-0.0125
Precedente Chiudi:
$0.3306
Aprire:
$0.326649
Volume 24 ore:
213.12K
Relative Volume:
1.27
Capitalizzazione di mercato:
$2.28M
Reddito:
-
Utile/perdita netta:
$-25.83M
Rapporto P/E:
-0.0472
EPS:
-6.7442
Flusso di cassa netto:
$-21.77M
1 W Prestazione:
-11.81%
1M Prestazione:
-59.35%
6M Prestazione:
-80.36%
1 anno Prestazione:
-96.59%
Intervallo 1D:
$0.3135
$0.3302
Intervallo di 1 settimana:
$0.3135
$0.3699
Portata 52W:
$0.3135
$19.20
Calidi Biotherapeutics Inc Stock (CLDI) Company Profile
Nome
Calidi Biotherapeutics Inc
Settore
Industria
Telefono
(858) 794-9600
Indirizzo
4475 Executive Drive, Suite 200, San Diego
Compare CLDI vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CLDI
Calidi Biotherapeutics Inc
|
0.3181 | 2.28M | 0 | -25.83M | -21.77M | -6.7442 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.34 | 119.23B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
745.77 | 78.84B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
700.45 | 43.35B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
313.41 | 41.57B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
284.05 | 31.51B | 5.36B | 287.73M | 924.18M | 2.5229 |
Calidi Biotherapeutics Inc Stock (CLDI) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2023-11-22 | Iniziato | H.C. Wainwright | Buy |
| 2023-10-09 | Iniziato | Robert W. Baird | Outperform |
Calidi Biotherapeutics Inc Borsa (CLDI) Ultime notizie
Calidi Biotherapeutics prices $5.2M underwritten public offering - MSN
Calidi Biotherapeutics Presents its Innovative and Scalable Manufacturing Process for CLD-401 at the 9th Annual Bioprocessing Summit; FDA Feedback Support Company’s Approach to Manufacturing - Sahm
Calidi Biotherapeutics Presents its Innovative and Scalable Manufacturing Process for CLD-401 at the 9th Annual Bioprocessing Summit; FDA Feedback Support Company's Approach to Manufacturing - Bitget
How a tumor-targeting virus therapy earned FDA support on its production - Stock Titan
Calidi Biotherapeutics Announces Proposed Public Offering of Common Stock and Warrants to Fund Growth Initiatives 12 - Minichart
Calidi Biotherapeutics Completes Dilutive Public Equity Offering - TipRanks
Calidi Biotherapeutics announces underwritten public offering - Investing.com Nigeria
Calidi Biotherapeutics Raises $6.03 Million in Unit Offering; Adds Warrant Agent and Amends Legacy Warrants - TradingView
Calidi Biotherapeutics (NYSE: CLDI) closes $6M unit and warrant deal - Stock Titan
Portfolio Update: Is Calidi Biotherapeutics Inc a stock for growth or value investors2026 Trading Volume Trends & Accurate Buy Signal Alerts - baoquankhu1.vn
CLDI PE Ratio & Valuation, Is CLDI Overvalued - Intellectia AI
Calidi Biotherapeutics Announces Closing of $6.0 Million Underwritten Public Offering and Full Exercise of Underwriters' Over-Allotment Option - Bitget
Calidi Biotherapeutics Announces Closing of $6.0 Million - GlobeNewswire
Calidi Biotherapeutics closes $6M public offering - Investing.com
Calidi Biotherapeutics Announces Closing of $6.0 Million Underwritten Public Offering and Full Exercise of Underwriters’ Over-Allotment Option - The Manila Times
Biotech Calidi raises $6M now, lines up $12M more with new warrants - Stock Titan
Calidi Biotherapeutics Announces Closing of $6.0 Million Underwritten Public Offering and Full Exercise of Underwriters’ Over-Allotment Option - GlobeNewswire Inc.
Investor Ognian Gavrilov reports 9.8% Calidi Biotherapeutics (CLDI) stake in Schedule 13D - Stock Titan
Calidi Biotherapeutics Prices $5.2 Mln Public Offering Of Shares And Warrants - Nasdaq
Calidi Biotherapeutics (CLDI) stock plunges 35% after hours — here's why - MSN
Published on: 2026-03-07 11:34:48 - baoquankhu1.vn
Growth Value: Is Calidi Biotherapeutics Inc forming a bullish divergenceTreasury Yields & Real-Time Chart Breakout Alerts - baoquankhu1.vn
Stop Loss: Does Calidi Biotherapeutics Inc have pricing powerJuly 2025 Summary & Daily Chart Pattern Signals - baoquankhu1.vn
Crude Oil Jumps Over 12%; US Retail Sales Fall In January - Benzinga
Calidi Biotherapeutics Announces Pricing of $5.2 Million Underwritten Public Offering - Bitget
Calidi prices 10.5M units at 50c in underwritten public offering - TipRanks
Calidi Biotherapeutics announces pricing of $5.2 million underwritten public offering - marketscreener.com
Calidi Biotherapeutics Announces Pricing Of $5.2 Million Underwritten Public Offering - TradingView
Calidi Biotherapeutics announces underwritten public offering By Investing.com - Investing.com Canada
Calidi Biotherapeutics (CLDI) files shelf supplement: 703,731 Units with warrants - Stock Titan
Calidi Biotherapeutics (CLDI) Stock Plunges 35% After HoursHere's Why - Finviz
Calidi Biotherapeutics Announces Public Offering, Shares Plunge 31% - Intellectia AI
Calidi Sinks On Proposed Public Offering; Shares Hit New 52-Week Low - Nasdaq
Calidi Biotherapeutics Announces Proposed Public Offering - The Manila Times
Biotech Calidi plans stock-and-warrant sale for working capital - Stock Titan
Calidi details characterization of CLD-401 for solid tumor treatment - BioWorld MedTech
CLDI Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Aug PreEarnings: Will Calidi Biotherapeutics Inc. stock recover after earningsJuly 2025 Weekly Recap & Daily Stock Trend Reports - baoquankhu1.vn
Quarterly Earnings: Is Calidi Biotherapeutics Inc a stock for growth or value investors - baoquankhu1.vn
CLDICalidi Biotherapeutics Inc Latest Stock News & Market Updates - Stock Titan
Is Calidi Biotherapeutics Inc. a momentum stockQuarterly Growth Report & Technical Entry and Exit Tips - mfd.ru
Can Calidi Biotherapeutics Inc. keep up with sector leadersJuly 2025 Fed Impact & Weekly Top Performers Watchlists - mfd.ru
Will Calidi Biotherapeutics Inc. stock benefit from AI adoptionEarnings Beat & Pattern Based Trade Signal System - mfd.ru
New virus-based tactic aims to revive T-cell engagers for solid tumors - Stock Titan
Will Calidi Biotherapeutics Inc. stock maintain strong growthEarnings Overview Summary & Safe Capital Investment Plans - mfd.ru
Energy Moves: Why analysts remain bullish on Calidi Biotherapeutics Inc. stockJuly 2025 Gainers & Community Verified Trade Signals - mfd.ru
Calidi Biotherapeutics To Present on its New Approach to Bispecific T-Cell Engagers (BiTEs) Using its RedTail Platform in a Late-Breaking Abstract at the 2026 AACR-IO Conference - Bitget
Engineered virus from Calidi delivers BiTEs into solid tumors - Stock Titan
Earnings Update: How much upside does Calidi Biotherapeutics Inc haveDividend Hike & Weekly Breakout Opportunity Watchlist - baoquankhu1.vn
Why analysts remain bullish on Calidi Biotherapeutics Inc. stock2025 Valuation Update & Safe Capital Growth Plans - mfd.ru
Is Calidi Biotherapeutics Inc. a stock for growth or value investorsPortfolio Update Report & Expert Verified Stock Movement Alerts - mfd.ru
Calidi Biotherapeutics Inc Azioni (CLDI) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.48%
1.21%
Capitalizzazione:
|
Volume (24 ore):